Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma
about
Dendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trialsThe interplay of immunotherapy and chemotherapy: harnessing potential synergiesAutologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer.Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasisPatients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of diseaseApigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer.A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft modelPotential survival benefit of anti-apoptosis protein: survivin-derived peptide vaccine with and without interferon alpha therapy for patients with advanced or recurrent urothelial cancer--results from phase I clinical trials.Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer.Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer.Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells.Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.Quantitative functional MRI in a clinical orthotopic model of pancreatic cancer in immunocompetent Lewis rats.Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model.Dendritic cells based immunotherapy.A bifunctional nanomodulator for boosting CpG-mediated cancer immunotherapy.PM01183 inhibits myeloid-derived suppressor cells in vitro and in vivo.Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer.Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells.Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.
P2860
Q27014829-75A72E49-AE2F-499D-A30F-28176A02B249Q28081893-6CEF763C-0F11-4272-851B-9F1664A91011Q33429758-5C0576B7-7432-444E-9251-CCFF66DB42F2Q35023580-CED32A89-9342-4215-ADC5-EDF02984FE93Q35857561-10F95AD8-A092-4443-9146-C09DA5454DC1Q36267629-AC0961A8-27B0-4053-AC6C-14A8CE049395Q36729501-F0CE7A34-8693-431C-BDF1-B6EE596350D0Q37393594-4ED9F868-89C8-4901-9467-DA2D66927237Q37671162-6BD8BC35-E5BD-4B1B-B8B0-DCB53DF27E9FQ38165930-40E0D2AC-3D87-48C5-BBAA-908D2F1A28C9Q38608986-FA668C5A-2E9E-4279-A206-00840BC1A8F2Q38767735-3F6E88EB-2E07-4761-9FC8-338FEC349642Q38820861-D8575957-8A88-47D6-B6D8-0B0C70FCD9DFQ39037817-535A15E8-6BAB-4A54-8072-DB96BDA32FECQ43043935-8015CC85-77D4-4AD5-9702-5A70A8C8958BQ50072990-6D401952-6650-4225-AAB1-B23FA9F4B467Q50213474-474CA2E0-D34D-4B33-8FE3-10DAC7C899DBQ50544084-56183D39-3632-4E7F-95D2-720D1DE4FB71Q52758913-73CF09A4-A665-48ED-82AF-C9A25731EC93Q55364385-4709AFE8-4B4E-4965-A201-ED8C82ED8B4F
P2860
Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Dendritic cell immunotherapy c ...... model of pancreatic carcinoma
@en
type
label
Dendritic cell immunotherapy c ...... model of pancreatic carcinoma
@en
prefLabel
Dendritic cell immunotherapy c ...... model of pancreatic carcinoma
@en
P2093
P2860
P1476
Dendritic cell immunotherapy c ...... model of pancreatic carcinoma
@en
P2093
Amod A Sarnaik
Gregory Springett
Kathleen Kinney
Krithika Kodumudi
Nasreen Vohra
Shari Pilon-Thomas
Tomar Ghansah
P2860
P2888
P304
P356
10.1007/S00262-013-1407-9
P577
2013-04-19T00:00:00Z